Browse Items (22 total)

• Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients

  Tags 2019-nCoV, Antibodies, Coronavirus, COVID-19, Immunology, Laboratory Testing, R-Lab, R-Res&Pub, Research, SARS-CoV-2
  Creator: Suthar, M. S., M. G. Zimmerman, R. C. Kauffman, G. Mantus, S. L. Linderman, W. H. Hudson, A. Vanderheiden, L. Nyhoff, C. W. Davis, O. Adekunle, M. Affer, M. Sherman, S. Reynolds, H. P. Verkerke, D. N. Alter, J. Guarner, J. Bryksin, M. C. Horwath, C.…
  Subject: Laboratory
  Item Type: Publication
  Date Last Updated: 2020-06-23
  Description: SARS-CoV-2, the virus responsible for COVID-19, is causing a devastating worldwide pandemic, and there is a pressing need to understand the development, specificity, and neutralizing potency of humoral immune responses during acute infection. We…
• 

  Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies.

  Tags Antibodies, Ebola, Immunology, Laboratory Testing, R-Res&Pub
  Creator: Geisen, C., G. Kann, T. Strecker, T. Wolf, G. Schüttfort, M. van Kraaij, S. MacLennan, S. Rummler, C. Weinigel, M. Eickmann, S. K. Fehling, V. Krähling, C. Seidl, E. Seifried, M. Schmidt, and R. Schäfer.
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2016-05
  Description: Ebola virus disease is a public health emergency of international concern, and enormous efforts are being made in the development of vaccines and therapies.

• Clinical Laboratory Values in Human Ebola Virus Disease Support the Relevance of the Intramuscular Ebola-Kikwit Rhesus Model.

  Tags Antibodies, Ebola, R-Res&Pub, Vaccine Study, Viral Hemorrhagic Fever
  Creator: Reisler, R. B., C. S. Kraft, S. Bavari, and A. P. Cardile
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2018-04-17
  Description: "To the Editor—We read with interest the recent article in Clinical Infectious Diseases by Lanini et al, which focused on the relationship between human Ebola virus (EBOV) RNA and clinical chemistry values obtained during the West African outbreak in…

• Ebola virus disease: implications for solid organ transplantation

  Tags Antibodies, Contact Transmission, Ebola, Infection Prevention and Control, R-DM, Viral Hemorrhagic Fever, Virology
  Creator: Kaul, D. R., A. K. Mehta, C. R. Wolfe, E. Blumberg, and M. Green
  Subject: Decedent Management
  Item Type: Publication
  Date Last Updated: 2015-01
  Description: The authors recommend a simple, common‐sense approach to screening deceased and living donors for exposure to Ebola virus and thus reducing the risk of Ebola virus transmission from organ donor to recipient.

• Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination.

  Tags Antibodies, Ebola, Immunology, R-Res&Pub, Vaccine Study, Virology
  Creator: Ellebedy, A. H., K. J. Jackson, H. T. Kissick, H. I. Nakaya, C. W. Davis, K. M. Roskin, A. K. McElroy, C. M. Oshansky, R. Elbein, S. Thomas, G. M. Lyon, C. F. Spiropoulou, A. K. Mehta, P. G. Thomas, S. D. Boyd, and R. Ahmed
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2016-10
  Description: Antigen-specific B cells bifurcate into antibody-secreting cells (ASCs) and memory B cells (MBCs) after infection or vaccination.
• 

  CC Grand Rounds: Response to an Outbreak: Ebola Virus Monoclonal Antibody (mAb114) Rapid Clinical Development
  

  Tags Antibodies, Ebola, Immunology, Prophylaxis, R-Res&Pub, Research, Therapeutics, Vaccine Study
  Creator: NIH
  Subject: Research
  Item Type: Video
  Date Last Updated: 2019-03-19
  Description: This is a one hour lecture about the monoclonal antibody (mAb114) and ebola. It requires Flash plugin.
• 

  Antibodies Against Ebola and Lassa

  Tags Antibodies, Ebola, Immunology, Lassa, R-Res&Pub, Vaccine Study, Viral Hemorrhagic Fever, Virology
  Creator: NIH
  Subject: Research
  Item Type: Video
  Date Last Updated: 2017-12-05
  Description: The 2017 Kinyoun Lecture discusses antibodies protecting against Ebola and Lassa, and the need for research collaboration.
• 

  Preparing for Serious Communicable Diseases in the United States: What the Ebola Virus Epidemic Has Taught Us

  Tags Antibodies, Contact Transmission, Critical Care, Droplet Transmission, Ebola, Epidemic, Infection Prevention and Control, Outbreaks, Patient Care, Personal Protective Equipment (PPE), Prophylaxis, Public Health, R-PPE, R-Res&Pub, Therapeutics, Vaccine Study, Viral Hemorrhagic Fever
  Creator: Varkey, J. B. and B. S. Ribner
  Subject: General
  Item Type: Publication
  Date Last Updated: 2016-06-01
  Description: Ending the West Africa Ebola virus disease (EVD) outbreak required an unprecedented international response.
• 

  Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease

  Tags Antibodies, Ebola, Immunology, Patient Care, R-Res&Pub, Therapeutics
  Creator: McElroy, A. K., J. R. Harmon, T. D. Flietstra, S. Campbell, A. K. Mehta, C. S. Kraft, M. G. Lyon, J. B. Varkey, B. S. Ribner, C. J. Kratochvil, P. C. Iwen, P. W. Smith, R. Ahmed, S. T. Nichol and C. F. Spiropoulou
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2016-08-15
  Description: Ebola virus (EBOV) infection causes a severe and often fatal disease.An updated was made in Erratum on 2017 July 5.
• 

  A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses

  Tags Antibodies, Immunology, Lassa, Patient Care, R-Res&Pub, Therapeutics
  Creator: McElroy, A. K., R. S. Akondy, J. R. Harmon, A. H. Ellebedy, D. Cannon, J. D. Klena, J. Sidney, A. Sette, A. K. Mehta, C. S. Kraft, M. G. Lyon, J. B. Varkey, B. S. Ribner, S. T. Nichol and C. F. Spiropoulou
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2017-06-15
  Description: A nurse who acquired Lassa virus infection in Togo in the spring of 2016 was repatriated to the United States for care at Emory University Hospital.